Research article · 30 Sep 2021
EditorialPublished 2012
Observational Data and Surrogate Endpoints are No Substitute for Randomized Clinical Trial Outcomes
Subjects
CardiologySimilar by topic
Conference abstract · 24 Apr 2017
The use of surrogate end points in pulmonary arterial hypertension: Enhancing clinical decision making by improving time to clinical worsening observations
Perspective · 29 Dec 2025
Surrogate Endpoints in Cancer Trials: Validity and Ethics
Review article · 12 May 2022
Motivational Interviewing Impact on Cardiac Rehabilitation Program Outcomes: A Systematic Review of Randomized Controlled Trials
Conference abstract · 27 Jul 2015
The effectiveness of a home-based interactive e-health educational intervention for middle-aged coronary heart disease (CHD) adults in improving total exercise, adherence rate, exercise efficacy and outcomes: A randomized controlled trial
More from this journal
The newest in Clinical and Experimental Cardiology.
Short communication · 4 Aug 2026
An effective determination method for aortic valve replacement through minimally invasive lower median sternotomy
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Wilbert S. Aronow”

